Molecular Mechanisms of Thymic Epithelial Cell Involution in Aging
Molecular Mechanisms of Thymic Epithelial Cell Involution in Aging
批准号:
8129711
负责人:
Bruce R Blazar
金额:
$31.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31
关键词:
3-DimensionalAdoptive TransferAdultAffectAgeAgingAging-Related ProcessAllelesApoptosisAtrophicBloodCell AgingCell Cycle ProgressionCell Differentiation processCell MaintenanceCell Surface ReceptorsCell physiologyCellsCharacteristicsClinicContractsDataDevelopmentEmbryonic DevelopmentEpithelial Cell ProliferationEventFibroblast Growth Factor Receptor 2FibroblastsGene DeletionGene ExpressionGenesGenetic ModelsGenotoxic StressGoalsHematopoietic stem cellsHomologous GeneHormonalImmuneImmune systemLabelLongevityLymphoidMicroRNAsModelingMolecularMusNatural regenerationPathway interactionsPharmaceutical PreparationsPhysiologicalPolycombPremature aging syndromeProductionProgeriaProtein IsoformsProteinsRepressionResidual stateSignal PathwaySignal TransductionSkinStem cellsStromal CellsSyndromeT-LymphocyteTestingTherapeutic InterventionThymic epithelial cellThymus GlandTimeTranscriptional RegulationWorkage relatedagedbiological adaptation to stresscell agefetalhuman TGFBR2 proteinimmune functioninsightkeratinocyte growth factor receptorloss of functionmTOR proteinprogenitorresponseself-renewalsenescencestem cell differentiationstemnesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Thymic involution constitutes a hallmark of an aging immune system. The thymus is comprised of thymic epithelial cells (TECs), fibroblasts and blood-borne stromal cells. Adoptive transfers of young and old hematopoietic stem cells into young vs old recipients has led to the conclusion that impaired thymopoiesis in the aged is largely the consequence of an aged thymic microenvironment. TEC differentiation, proliferation, and survival are controlled by cell intrinsic and extrinsic factors. Although much work has been focused on thymus development during embryogenesis, comparatively little is known about the mechanisms responsible for thymic involution. This especially pertains to TECs, which we hypothesize are the major impediment to thymopoiesis during aging. We now propose to fill this critical gap. Our specific aims are: Aim 1: To determine the key transcription factors & signaling pathways in TECs affected by aging. In aim 1A, we will interrogate physiological characteristics of aged vs young TEC subsets. In aim 1B, we hypothesize that key cell surface receptor and intracellular transcriptional pathways that regulate thymic development will be important for TEC maintenance and regeneration after genotoxic stress in aged mice. In aim 1C, we hypothesize that transcriptional regulation by micro-RNAs is an important component of TEC aging. Studies of loss-of-function in TECs alone will be performed in aims 1B and 1C. Aim 2: To test the hypothesis that genetic models of perturbations of the aging process will provide key insights as to the mechanisms responsible for TEC aging. We will identify common features affecting TECs between chronologically aged mice and those with premature aging and distinguishing features in a model of delayed thymic aging. As indicated, drugs that stimulate TECs as probes for assessing residual TEC function in aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
-
批准号:10763967
-
项目类别:
-
资助金额:$772.72万
-
财政年份:2023
-
负责人:Bruce R Blazar
-
依托单位:
In Vivo Prevention of Murine GVHD
-
批准号:10362877
-
项目类别:
-
资助金额:$60.35万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Metabolomics of cGVHD
-
批准号:10698171
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
In Vivo Prevention of Murine GVHD
-
批准号:10610863
-
项目类别:
-
资助金额:$58.97万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Metabolomics of cGVHD
-
批准号:10493800
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2022
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10560605
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10092348
-
项目类别:
-
资助金额:$67.52万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
-
批准号:10348683
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2021
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10305635
-
项目类别:
-
资助金额:$6.75万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10656502
-
项目类别:
-
资助金额:$81.18万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:9888096
-
项目类别:
-
资助金额:$84.95万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
-
批准号:10532723
-
项目类别:
-
资助金额:$75.14万
-
财政年份:2019
-
负责人:Bruce R Blazar
-
依托单位:
University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
-
批准号:9901640
-
项目类别:
-
资助金额:$697.02万
-
财政年份:2018
-
负责人:Bruce R Blazar
-
依托单位:
University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)
-
批准号:10366062
-
项目类别:
-
资助金额:$577.8万
-
财政年份:2018
-
负责人:Bruce R Blazar
-
依托单位:
Preclinical Drug Approaches to Chronic GVHD Prevention and Treatment
-
批准号:8881478
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2015
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:8837683
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Mechanisms, Prevention and Treatment of Chronic GVHD
-
批准号:8746996
-
项目类别:
-
资助金额:$62.81万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:10616775
-
项目类别:
-
资助金额:$69.68万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:8690244
-
项目类别:
-
资助金额:$44.3万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
Enhancing Treg Therapeutic Efficacy in GVHD
-
批准号:10452167
-
项目类别:
-
资助金额:$72.25万
-
财政年份:2014
-
负责人:Bruce R Blazar
-
依托单位:
海外基金